Continuation Protocol to Protocol BBCO-001

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

October 31, 2017

Study Completion Date

December 31, 2017

Conditions

Muscular Dystrophy, Oculopharyngeal (OPMD)

Interventions

DRUG

Tehalose 30gr

Trehalose 30 g for IV infusion administered every week over an additional 52 weeks

Trial Locations (1)

Montreal Neurological Institute, McGill University, Montreal